Friday 11th November 2022 |
Text too small? |
EROAD will release its financial results for the 6 months ended 30 September 2022 on Friday 25th November.
EROAD’s Chief Executive Officer, Mark Heine, and Acting Chief Financial Officer, Margaret Warrington, will give a presentation on the company's financial and operational performance for H1 FY23 via a webinar commencing on Friday 25 November 2021 at 11:00am NZT.
Webinar details:
Topic: EROAD H1 FY23 Financial Results Announcement
When: November 25, 2022
Time: 11:00 AM NZT
Register in advance for this webinar:
https://us02web.zoom.us/webinar/register/WN__rXDI0XdTd2LRf4AWduN5w
After registering, you will receive a confirmation email containing information about joining the webinar.
A replay of this webinar will be available once it has been uploaded to the EROAD website under ‘presentations’ on https://www.eroadglobal.com/global/investors/
ENDS
Authorised for release to the NZX and ASX by EROAD's General Counsel & Company Secretary, Ksenija Chobanovich.
For Investor enquiries please contact:
Anna Bonney
Investor Relations
+64 218 441 55 anna@merlinconsulting.co.nz
For Media enquiries please contact:
Hugo Shanahan
Hugo@shanahan.nz
About EROAD
EROAD Limited (ASX: ERD; NZX: ERD ) (“EROAD”) purpose is safer and more sustainable roads. EROAD develops and markets technology solutions to manage vehicle fleets, support regulatory compliance, improve driver safety and reduce the costs associated with operating a fleet of vehicles and inventory of assets. EROAD has a proven SaaS business model and is experiencing continuing growth in installed units and revenue. EROAD has operations in New Zealand, North America and Australia with customers ranging in size from small fleets through to large enterprise customers. For more information visit https://www.eroadglobal.com/investors
No comments yet
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b